Gabapentin Tablet
Product Images NDC 71335-0254

This appears to be a table or chart with information about pain scores and dosage of gabapentin. The table includes columns for different dosage periods and rows for differing levels of gabapentin and placebo. Unfortunately, as there is not enough context provided, it is not possible to determine how to interpret the data presented.*

The text shows a figure (Figure 3) that displays the proportion of responders (patients who had a 50% reduction in pain score) in controlled PHN (post-herpetic neuralgia) studies. The studies are referred to as Study 1 and Study 2. The figure has bar graphs that represent the percentage of responders for different treatments - PBO (placebo), GBP 3600 (unknown drug), GBP 1800 (unknown drug), and GBP 2400 (unknown drug). The figure also has symbols - two asterisks (*) and asterisk plus (+), which most likely indicate statistical significance. Overall, the text is a visual representation of data obtained from clinical trials related to pain management.*

This text provides formulas for calculating two medical indicators: Hbr and an unspecified calculation related to age and weight. Hbr is calculated by multiplying 72 by the patient's serum creatinine level in milligrams per deciliter. For female patients, the result is further multiplied by 0.85. Unfortunately, the exact calculation using age and weight is not provided in this text.*

This appears to be a comparison of a medication called "Neurontin 800mg Tablet" by Glenmark Pharmaceuticals Limited with another medication that was prepackaged by Bryant Ranck. The package includes an NDC number and storage instructions, but no further information is available.*